How AI Is Shaping the Future of CAR T and Myeloma Care
https://vimeo.com/1158519733 Exploring the intersection of artificial intelligence and next-generation cancer therapies, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of The…
Staying [ACT]IVATED Ahead of Relapse: Improving CAR T Durability in Myeloma
https://vimeo.com/1158519769 In a forward-looking discussion on the future of CAR T-cell therapy, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of…
Miguel’s Journey: Embracing CAR T-cell Therapy as a Latinx Myeloma Survivor
https://vimeo.com/951627946 Myeloma survivor Miguel wasn’t experiencing any symptoms when he received his shocking diagnosis. Watch as he shares his experience as a Latinx myeloma patient dealing with testing, multiple lines…
What CAR T Research Is Ongoing to Improve Treatment Response?
https://vimeo.com/944064596 How can CAR T treatment response be improved with research? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center discusses the CARTITUDE, KARMMA-9, and LEGEND studies…
Are There Myeloma Trials Investigating CAR T for Frontline Therapy?
Are There Myeloma Trials Investigating CAR T for Frontline Therapy? from Patient Empowerment Network on Vimeo. Is it possible for CAR T-cell therapy to be used as a frontline therapy?…
Reducing CAR T-Cell Therapy Barriers for Relapsed/Refractory Myeloma
https://vimeo.com/926992265 How can CAR T-cell therapy barriers for relapsed/refractory myeloma be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic shares his perspective about barriers to CAR T and advice for patients to…